CD83 and B-cell chronic lymphocytic leukemia: The same trend was observed in the levels of CD83 mRNA expression of patients with chronic lymphocytic leukemia in the CLL cohort, patients with metastatic gastric cancer in the mGC cohort, and patients with metastatic urothelial carcinoma in the mUC cohort (Fig. 5D).